The FACR announces the release of the most recent phase results from the QOL study, updated December 2012, which to date show an extraordinary accumulated positive response rate of 65%. Click here to find in-depth information on the results, including specific responses as well as methods employed in assessment and measurement.
About quality of life
"Quality of life" is defined as the degree of well-being felt by an individual or group of people. Quality of life is particularly important in health care, where treatment decisions and side effects directly impact a patient’s functionality and ability to enjoy normal life activities.
The classic evaluation of the success of treatment focuses on “response,” or alterations in physical condition. While this marker is obviously of great importance, it ignores the serious impairment that treatments can have on patients’ quality of life.
Quality of life is particularly important in the areas of cancer and chronic disease, where patients often suffer from debilitating side effects as a result of standardized treatments. Unfortunately, a poor quality of life is something most of these patients are told they have to live with if they want to get well.
About the study
The FACR, in conjunction with AMARC Enterprises, is conducting a Quality of Life Study. We recommend Poly-MVA (palladium lipoic complexes) as a product that can assist those people who suffer from various forms and stages of cancer. Compelling evidence indicates that it can support the body to target and eradicate cancerous cells without damaging healthy ones. To learn more about Poly-MVA, click here.
With this QOL study, we carefully evaluate the total effect that Poly-MVA and/or other treatments have on a person. It is not enough to simply know how a medical treatment preserves life or controls disease. The correct benchmarks for success must examine the whole patient- including physical, psychological, and emotional state. Ultimately, the measurement of the success of any treatment must take into account the very personal perception of patients regarding their overall wellbeing and happiness.
While quality of life is generally considered an intangible phenomenon, we have developed condition-specific monitoring techniques to address certain aspects of wellbeing that are considered universally important. This research study aims to gather information on parameters such as energy, mood, efficacy and others. These will be tracked on a monthly basis in relation to the use of Poly-MVA.
Should you wish to participate in this Quality of Life Study, a number of benefits will be available to you. First of all, you will have the opportunity to experience the benefits thousands of people enjoy every day as a result of Poly-MVA. Secondly, for every month you are enrolled in the study you will be able to purchase Poly-MVA from AMARC Enterprises at a 50% discount.
Downloaded files can be filled out in Acrobat and emailed to firstname.lastname@example.org, or submitted by fax at 619-447-6501 or by mail to:
Attn: QOL Study/FACR
2514 Jamacha Rd # 502-196
El Cajon, CA 92019
If you do not have Adobe Acrobat, you can download it for free. If this is not possible, call AMARC at 1-800-960-6760 and they will fax or mail the forms to you.
If you have questions or would like further information on Poly-MVA or this study, please contact us at 1-866-5CANCER (866-522-6237).
Your participation in this research, in conjunction with others like yourself, will provide invaluable data and further insight into the use, safety and quality of life that Poly-MVA may provide. Thank you very much for your commitment to support further research.
|To read survivor stories from previous QOL Study participants, click here.|